These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 448093)

  • 1. Genetic study of mouse sensitivity to MHV3 infection: influence of the H-2 complex.
    Lévy-Leblond E; Oth D; Dupuy JM
    J Immunol; 1979 Apr; 122(4):1359-62. PubMed ID: 448093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically determined resistance to mouse hepatitis virus 3 is expressed in hematopoietic donor cells in radiation chimeras.
    Dupuy JM; Dupuy C; Décarie D
    J Immunol; 1984 Sep; 133(3):1609-13. PubMed ID: 6146650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TEMV-specific delayed-type hypersensitivity.
    Clatch RJ; Melvold RW; Miller SD; Lipton HL
    J Immunol; 1985 Aug; 135(2):1408-14. PubMed ID: 3925009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in genetic control of susceptibility to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Differences between susceptible SJL/J and resistant BALB/c strains map near the T cell beta-chain constant gene on chromosome 6.
    Melvold RW; Jokinen DM; Knobler RL; Lipton HL
    J Immunol; 1987 Mar; 138(5):1429-33. PubMed ID: 3027179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoregulation in murine malaria. Susceptibility of inbred mice to infection with Plasmodium yoelii depends on the dynamic interplay of host and parasite genes.
    Sayles PC; Wassom DL
    J Immunol; 1988 Jul; 141(1):241-8. PubMed ID: 3379305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice.
    Wolfgram LJ; Beisel KW; Herskowitz A; Rose NR
    J Immunol; 1986 Mar; 136(5):1846-52. PubMed ID: 3005402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired T and B cell subpopulations involved in a chronic disease induced by mouse hepatitis virus type 3.
    Jolicoeur P; Lamontagne L
    J Immunol; 1994 Aug; 153(3):1318-7. PubMed ID: 8027559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic control of low-dose streptozotocin-induced autoimmune diabetes in mice.
    Kiesel U; Falkenberg FW; Kolb H
    J Immunol; 1983 Apr; 130(4):1719-22. PubMed ID: 6833751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid resistance to BALB/c plasmacytomas. I. Resistance to MPC-11 controlled by a locus not linked to H-2.
    Walker MC; Phillips-Quagliata JM
    J Immunol; 1979 Apr; 122(4):1535-43. PubMed ID: 448097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental murine hypersensitivity pneumonitis: multigenic control and influence by genes within the I-B subregion of the H-2 complex.
    Wilson BD; Sternick JL; Yoshizawa Y; Katzenstein AL; Moore VL
    J Immunol; 1982 Nov; 129(5):2160-3. PubMed ID: 6811659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute-phase reactants of mice. II. Strain dependence of serum amyloid P-component (SAP) levels and response to inflammation.
    Mortensen RF; Beisel K; Zeleznik NJ; Le PT
    J Immunol; 1983 Feb; 130(2):885-9. PubMed ID: 6600258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphokine release as measurement of anti-mouse hepatitis virus type 3 (MHV3) cellular reactions in various mouse lines exhibiting differential susceptibilities to MHV3-induced paralysis.
    Mansour S; Mercier G; Oth D
    Acta Virol; 1990 Sep; 34(5):423-32. PubMed ID: 1981453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-induced immune complex disease: genetic control of C1q binding complexes in the circulation of mice persistently infected with lymphocytic choriomeningitis virus.
    Oldstone MB; Tishon A; Buchmeier MJ
    J Immunol; 1983 Feb; 130(2):912-8. PubMed ID: 6217255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H-2-controlled genetic susceptibility to pulmonary adenomas induced by urethane and 4-nitroquinoline 1-oxide in A/Wy congenic strains.
    Miyashita N; Moriwaki K
    Jpn J Cancer Res; 1987 May; 78(5):494-8. PubMed ID: 3112061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg.
    Milich DR; Chisari FV
    J Immunol; 1982 Jul; 129(1):320-5. PubMed ID: 6177755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice.
    Lipton HL; Melvold R
    J Immunol; 1984 Apr; 132(4):1821-5. PubMed ID: 6699403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse hepatitis virus 3 pathogenicity expressed by a lytic viral infection in bone marrow 14.8+ mu+ B lymphocyte subpopulations.
    Jolicoeur P; Lamontagne L
    J Immunol; 1989 Dec; 143(11):3722-30. PubMed ID: 2555417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse hepatitis virus 3 replication in T and B lymphocytes correlate with viral pathogenicity.
    Lamontagne L; Descoteaux JP; Jolicoeur P
    J Immunol; 1989 Jun; 142(12):4458-65. PubMed ID: 2542412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of H-2:H-7 congenic mice to study H-2-mediated resistance to Friend leukemia virus.
    Wettstein PJ; Blank KJ
    J Immunol; 1982 Jul; 129(1):358-61. PubMed ID: 7086137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target determinants for F1 hybrid anti-parental H-2d cell-mediated lympholysis: self antigens controlled by the D end.
    Nakamura I; Nakano K; Cudkowicz G
    J Immunol; 1983 May; 130(5):2429-33. PubMed ID: 6187857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.